Ghent University Academic Bibliography

1 – 5 of 5

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?q=author%3D%22Labourey%2C+JL*%22+or+(type+exact+bookEditor+and+editor%3D%22Labourey%2C+JL*%22)&embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

2012
- A1
- journalArticle
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study
JG Aerts, A Swieboda-Sadlej, C Karanikiotis, JL Labourey, A Galid, T Wheeler, B Pujol and Simon Van Belle UGent (2012) CURRENT MEDICAL RESEARCH AND OPINION. 28(7). p.1089-1099 Mark
- A1
- journalArticle
A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice
Simon Van Belle UGent, A Swieboda-Sadlej, C Karanikiotis, JL Labourey, A Galid, T Wheeler, B Pujol and JG Aerts (2012) CURRENT MEDICAL RESEARCH AND OPINION. 28(7). p.1079-1087 Mark
2011
- A1
- journalArticle
Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy: data from the CHOICE study
Simon Van Belle UGent, C Karanikiotis, JL Labourey, A Galid, T Wheeler and B Pujol (2011) CURRENT MEDICAL RESEARCH AND OPINION. 27(5). p.987-994 Mark
- C3
- conference
Use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia in European clinical practice: data from the CHOICE study
Simon Van Belle UGent, A Galid, C Karanikiotis, T Wheeler, B Pujol and JL Labourey (2011) EUROPEAN JOURNAL OF CANCER. 47(suppl. 1). p.S265-S265 Mark
- C3
- conference
Darbepoetin alfa effectiveness in breast cancer patients: data from the CHOICE study
Simon Van Belle UGent, C Karanikiotis, JL Labourey, A Galid, T Wheeler and B Pujol (2011) BREAST. 20(suppl. 1). p.S81-S81 Mark